Orthopediatrics Corp KIDS
We take great care to ensure that the data presented and summarized in this overview for ORTHOPEDIATRICS CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding KIDS
View all-
Brown Capital Management LLC Baltimore, MD2.79MShares$90.6 Million1.46% of portfolio
-
Brown Advisory Inc1.65MShares$53.5 Million0.07% of portfolio
-
Black Rock Inc. New York, NY1.22MShares$39.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.11MShares$36 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA884KShares$28.7 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA732KShares$23.8 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA726KShares$23.6 Million0.76% of portfolio
-
New York State Common Retirement Fund562KShares$18.2 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX507KShares$16.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT501KShares$16.3 Million0.08% of portfolio
Latest Institutional Activity in KIDS
Top Purchases
Top Sells
About KIDS
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Insider Transactions at KIDS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
David R Bailey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
90,395
+28.23%
|
-
|
|
Jun 11
2024
|
Fred Hite COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
57,018
+27.4%
|
-
|
|
Jun 11
2024
|
Gregory A Odle President of Scoliosis |
BUY
Grant, award, or other acquisition
|
Direct |
34,901
+23.22%
|
-
|
|
Jun 11
2024
|
Mark C Throdahl Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,623
+11.94%
|
-
|
|
Jun 11
2024
|
Joseph W Hauser Pres. Trauma & Def. Correction |
BUY
Grant, award, or other acquisition
|
Direct |
37,936
+29.47%
|
-
|
|
Jun 11
2024
|
Daniel J Gerritzen General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
34,901
+28.56%
|
-
|
|
Jun 10
2024
|
Harold Ruf Director |
BUY
Bona fide gift
|
Indirect |
2,766
+12.57%
|
-
|
|
Jun 10
2024
|
Harold Ruf Director |
SELL
Bona fide gift
|
Direct |
2,766
-100.0%
|
-
|
|
May 28
2024
|
David R Pelizzon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+10.13%
|
-
|
|
May 28
2024
|
Bryan W Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+17.74%
|
-
|
|
May 28
2024
|
Terry D Schlotterback Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+13.18%
|
-
|
|
May 28
2024
|
George Sinclair Mitchell Dyer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+36.89%
|
-
|
|
May 28
2024
|
Samuel D Riccitelli Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+18.7%
|
-
|
|
May 28
2024
|
(Reynolds) Marie C Infante Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+19.57%
|
-
|
|
May 28
2024
|
Harold Ruf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+30.42%
|
-
|
|
May 28
2024
|
Jimmy Duane Mc Donald Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+36.89%
|
-
|
|
Mar 11
2024
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
3,195
-3.28%
|
$86,265
$27.59 P/Share
|
|
Mar 11
2024
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
2,433
-1.73%
|
$65,691
$27.59 P/Share
|
|
Mar 11
2024
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
2,768
-3.33%
|
$74,736
$27.59 P/Share
|
|
Mar 11
2024
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,741
-4.97%
|
$74,007
$27.59 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 315K shares |
|---|---|
| Exercise of conversion of derivative security | 670 shares |
| Bona fide gift | 6.23K shares |
| Payment of exercise price or tax liability | 529 shares |
|---|---|
| Open market or private sale | 24.2K shares |
| Bona fide gift | 8.53K shares |